Xianyun Qin
Jining, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Bone Marrow Mesenchymal Stem Cells Derived from Acute Myeloid Leukemia Patients Contribute to Leukemia Cell Survival Through Decorin/Matrix Metalloproteinase-2 Crosstalk.
Journal: Stem cells and development
Published: December 29, 2025
Galectin-1: An important regulator in myeloid differentiation and acute myeloid leukemia as well as a promising prognostic indicator and therapeutic target.
Journal: International immunopharmacology
Published: February 04, 2025
FANCI is involved in the malignant progression of glioma cells by regulating the Akt/Bcl-2 signaling pathway.
Journal: Discover oncology
Published: September 22, 2024
Plasma-derived exosomes contributes to endothelial-to-mesenchymal transition in Moyamoya disease.
Journal: Heliyon
Published: July 10, 2023
Function of Long Noncoding RNAs in Glioma Progression and Treatment Based on the Wnt/β-Catenin and PI3K/AKT Signaling Pathways.
Journal: Cellular and molecular neurobiology
Published: April 28, 2023
Shikonin Induces Glioma Necroptosis, Stemness Decline, and Impedes (Immuno)Proteasome Activity.
Journal: Stem cells international
Published: December 30, 2022
Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio in Patients With Newly Diagnosed Moyamoya Disease: A Cross-Sectional Study.
Journal: Frontiers in neurology
Published: November 20, 2020
Corilagin induces human glioblastoma U251 cell apoptosis by impeding activity of (immuno)proteasome.
Corilagin induces human glioblastoma U251 cell apoptosis by impeding activity of (immuno)proteasome.
Journal: Oncology reports
Published: September 04, 2020
Corilagin induces apoptosis and autophagy in NRF2‑addicted U251 glioma cell line.
Journal: Molecular medicine reports
Published: May 26, 2020
Amino Acid-Mediated Metabolism: A New Power to Influence Properties of Stem Cells.
Journal: Stem cells international
Published: August 10, 2019
Genetic analysis of the ATG16L1 gene promoter in sporadic Parkinson's disease.
Journal: Neuroscience letters
Published: February 07, 2017
Last Updated: 09/26/2026